Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
AI could appreciably improve the delivery of healthcare services to patients—if only people trusted it. For many, the difference-maker would be nicely crafted federal regulations.
From boutique clinics in Mexico to medical spas in Europe to top-tier academic medical centers in the U.S., healthcare organizations courting medical tourists are enjoying boom times.
Every industry on earth is buzzing over the promise and potential of ChatGPT and similarly sharp AI models, whether “large language” or another generative form. Healthcare is no exception. But shouldn’t it be?
Fresh off its success using AI to develop a blockbuster COVID vaccine, up-and-coming biotech player Moderna (founded 2010) has won the confidence of 112-year-old Big Blue as a strategic partner.
Having identified an “urgent” need for guardrails to keep healthcare AI from veering into an avoidable ditch, the Coalition for Health AI has put together a 24-page guide applicable to numerous groups of stakeholders.
ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.
